Reassessment of the recurrence risk of primary gastrointestinal stromal tumour after complete resection

被引:5
作者
Yang, Weili [1 ]
Shou, Chunhui [1 ]
Chen, Zhou [1 ]
Hong, Yanyun [1 ]
Yu, Hang [1 ]
Wang, Xiaodong [1 ]
Wu, Zihan [2 ]
Zhang, Qing [1 ]
Gao, Yuan [1 ]
Yu, Jiren [1 ,3 ]
机构
[1] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Gastrointestinal Surg, Hangzhou, Peoples R China
[2] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Pathol, Hangzhou, Peoples R China
[3] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Gastrointestinal Surg, 79 Qingchun Rd, Hangzhou, Peoples R China
关键词
Gastrointestinal stromal tumour; prognostic nutritional index; recurrence; risk assessment; surgical treatment; NEUTROPHIL-TO-LYMPHOCYTE; PROGNOSTIC-FACTORS; DIAGNOSIS; INDEX;
D O I
10.1080/00365521.2022.2158752
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Impact statementsA further modification to the NIH risk criteria for GISTs was proposed ('NIH-PNI stratification'). Non-high risk (NHR) patients were divided into NHR-PNI-H and NHR-PNI-L groups. High risk (HR) patients were divided to HR1, HR2 and HR3 groups. The five-year RFS rates were 97.3%, 93.5%, 74.1%, 61.7% and 24.4%, respectively (p < .001). The AUC for the NIH-PNI stratification, modified NIH criteria, NIH criteria (2002), AFIP criteria and nomogram were 0.857, 0.807, 0.817, 0.843 and 0.831. ObjectivesThe modified National Institutes of Health (NIH) risk criteria for gastrointestinal stromal tumours (GISTs) have some limitations and need to be improved.MethodsPatients who underwent radical resection of primary GIST were retrospectively reviewed. Peripheral blood indices including the neutrophil-to-lymphocyte ratio (NLR) and prognostic nutritional index (PNI) were analysed. Recurrence-free survival (RFS) was calculated and compared. Multivariate analysis was conducted. Area under the receiver operating characteristic curve (ROC) was calculated.ResultsA total of 492 patients were enrolled. Tumour size, mitotic index (MI), tumour location and PNI were independent prognostic factors. The modified NIH criteria could not distinguish among very low-, low- and intermediate-risk patients, and PNI was the only independent prognostic factors for them. The five-year RFS rate in the high risk (HR) group was significantly lower. A further modification to the NIH risk criteria was proposed (the 'NIH-PNI stratification'). Non-high risk (NHR) patients were divided into the NHR-PNI-H group (PNI > 48.05) and the NHR-PNI-L group (PNI <= 48.05), respectively. HR patients were divided according to tumour size and MI: the HR1, HR2 and HR3 groups. The five-year RFS rates of the NHR-PNI-H, NHR-PNI-L, HR1, HR2 and HR3 groups were 97.3%, 93.5%, 74.1%, 61.7% and 24.4%, respectively (p < .001). The area under the curve (AUC) for the NIH-PNI stratification, modified NIH criteria, NIH criteria (2002), AFIP criteria and nomogram were 0.857, 0.807, 0.817, 0.843 and 0.831, respectively.ConclusionThe proposed NIH-PNI stratification was able to distinguish among five groups in terms of risk of recurrence.
引用
收藏
页码:684 / 692
页数:9
相关论文
共 23 条
[1]   Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up (vol 29, pg 68, 2018) [J].
Casali, P. G. ;
Abecassis, N. ;
Aro, H. T. ;
Bauer, S. ;
Biagini, R. ;
Bielack, S. ;
Bonvalot, S. ;
Boukovinas, I. ;
Bovee, J. V. M. G. ;
Brodowicz, T. ;
Broto, J. M. ;
Buonadonna, A. ;
De Alava, E. ;
Tos, A. P. Dei ;
Del Muro, X. G. ;
Dileo, P. ;
Eriksson, M. ;
Fedenko, A. ;
Ferraresi, V. ;
Ferrari, A. ;
Ferrari, S. ;
Frezza, A. M. ;
Gasperoni, S. ;
Gelderblom, H. ;
Gil, T. ;
Grignani, G. ;
Gronchi, A. ;
Haas, R. L. ;
Hassan, B. ;
Hohenberger, P. ;
Issels, R. ;
Joensuu, H. ;
Jones, R. L. ;
Judson, I. ;
Jutte, P. ;
Kaal, S. ;
Kasper, B. ;
Kopeckova, K. ;
Krakorova, D. A. ;
Le Cesne, A. ;
Lugowska, I. ;
Merimsky, O. ;
Montemurro, M. ;
Pantaleo, M. A. ;
Piana, R. ;
Picci, P. ;
Piperno-Neumann, S. ;
Pousa, A. L. ;
Reichardt, P. ;
Robinson, M. H. .
ANNALS OF ONCOLOGY, 2018, 29 :267-267
[2]   Two hundred gastrointestinal stromal tumors - Recurrence patterns and prognostic factors for survival [J].
DeMatteo, RP ;
Lewis, JJ ;
Leung, D ;
Mudan, SS ;
Woodruff, JM ;
Brennan, MF .
ANNALS OF SURGERY, 2000, 231 (01) :51-58
[3]   Combination of PLR, MLR, MWR, and Tumor Size Could Significantly Increase the Prognostic Value for Gastrointestinal Stromal Tumors [J].
Feng, Fan ;
Tian, Yangzi ;
Liu, Shushang ;
Zheng, Gaozan ;
Liu, Zhen ;
Xu, Guanghui ;
Guo, Man ;
Lian, Xiao ;
Fan, Daiming ;
Zhang, Hongwei .
MEDICINE, 2016, 95 (14)
[4]   Diagnosis of gastrointestinal stromal tumors: A consensus approach [J].
Fletcher, CDM ;
Berman, JJ ;
Corless, C ;
Gorstein, F ;
Lasota, J ;
Longley, BJ ;
Miettinen, M ;
O'Leary, TJ ;
Remotti, H ;
Rubin, BP ;
Shmookler, B ;
Sobin, LH ;
Weiss, SW .
INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2002, 10 (02) :81-89
[5]   Blood neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios are independent prognostic factors for surgically resected gastrointestinal stromal tumors [J].
Goh, Brian K. P. ;
Chok, Aik-Yong ;
Allen, John C., Jr. ;
Quek, Richard ;
Teo, Melissa C. C. ;
Chow, Pierce K. H. ;
Chung, Alexander Y. F. ;
Ong, Hock-Soo ;
Wong, Wai-Keong .
SURGERY, 2016, 159 (04) :1146-1156
[6]   Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysis [J].
Gold, Jason S. ;
Goenen, Mithat ;
Gutierrez, Antonio ;
Martin Broto, Javier ;
Garcia-del-Muro, Xavier ;
Smyrk, Thomas C. ;
Maki, Robert G. ;
Singer, Samuel ;
Brennan, Murray F. ;
Antonescu, Cristina R. ;
Donohue, John H. ;
DeMatteo, Ronald P. .
LANCET ONCOLOGY, 2009, 10 (11) :1045-1052
[7]   Risk stratification of patients diagnosed with gastrointestinal stromal tumor [J].
Joensuu, Heikki .
HUMAN PATHOLOGY, 2008, 39 (10) :1411-1419
[8]   Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts [J].
Joensuu, Heikki ;
Vehtari, Aki ;
Riihimaki, Jaakko ;
Nishida, Toshirou ;
Steigen, Sonja E. ;
Brabec, Peter ;
Plank, Lukas ;
Nilsson, Bengt ;
Cirilli, Claudia ;
Braconi, Chiara ;
Bordoni, Andrea ;
Magnusson, Magnus K. ;
Linke, Zdenek ;
Sufliarsky, Jozef ;
Federico, Massimo ;
Jonasson, Jon G. ;
Dei Tos, Angelo Paolo ;
Rutkowski, Piotr .
LANCET ONCOLOGY, 2012, 13 (03) :265-274
[9]   Impact of age and gender on tumor related prognosis in gastrointestinal stromal tumors (GIST) [J].
Kramer, Klaus ;
Knippschild, Uwe ;
Mayer, Benjamin ;
Boegelspacher, Kira ;
Spatz, Hanno ;
Henne-Bruns, Doris ;
Agaimy, Abbas ;
Schwab, Matthias ;
Schmieder, Michael .
BMC CANCER, 2015, 15
[10]   Chinese consensus guidelines for diagnosis and management of gastrointestinal stromal tumor [J].
Li, Jian ;
Ye, Yingjiang ;
Wang, Jian ;
Zhang, Bo ;
Qin, Shukui ;
Shi, Yingqiang ;
He, Yulong ;
Liang, Xiaobo ;
Liu, Xiufeng ;
Zhou, Ye ;
Wu, Xin ;
Zhang, Xinhua ;
Wang, Ming ;
Gao, Zhidong ;
Lin, Tianlong ;
Cao, Hui ;
Shen, Lin .
CHINESE JOURNAL OF CANCER RESEARCH, 2017, 29 (04) :281-293